Drug
Biphasic Insulin Aspart
Biphasic Insulin Aspart: highest development phase Post-Market, developed by Novo Nordisk. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| biphasic insulin aspart NCT00282451 | Post-Market | Diabetes |
Latest
No recent events.
Follow Biphasic Insulin Aspart on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.